SB Life Science Ventures I, L.P. was launched in 2001 with the objective of capitalizing on investment opportunities in the health care and biomedical sectors. With committed capital of about $100 million, the Fund aims to identify and invest in exceptional businesses that have the potential to transform the practice of medicine and health care.

The Fund is managed by SB Life Science located in California, USA and Tokyo, JAPAN with a professional team that has extensive experience in management consulting, venture capital financing, hospital management, start-up mentoring and cross-border business development.

SB Life Science is a health care focused fund backed by prominent institutional and corporate investors from Japan. SOFTBANK, the Japanese high-tech giant, is the original sponsor of the Fund. Additional limited partners include leading Japanese banks, financial institutions, insurance and industrial corporations.

Together with our professional team’s business and technical background as well as the Asian network of our institutional investors, SB Life Science provides a solid source of capital as well as a unique and valuable resource for our portfolio companies.